Health and Healthcare
584 Articles
There may be some speculation that drug giant Pfizer Inc. (NYSE: PFE) is looking at expansion through acquisitions. The FT…
People who get to the end of 2008 and are still at work can be thankful. The unemployment rate will…
According to Reuters, the Fed may need to use a trillion dollars to halt the economy from moving into a…
There are few positive calls this morning from Wall Street analysts, but these are the ones we have caught this…
These are some of the top analyst upgrades we have seen this Friday morning: Abercrombie & Fitch (ANF) Raised to…
Analysts assume third quarter earnings for the companies in the S&P 500 will be bad. But, looking at the number…
Carl Icahn appears to have won a blue ribbon for ImClone Systems (NASDAQ: IMCL) shareholders. The biotech stock is trading…
ImClone Systems Inc. (NASDAQ: IMCL) is among the biotech bonanza merger candidates with one deal on the table and perhaps…
According to Reuters, Wilbur Ross say the bailout package does not address the core of problem which is mortgage payments.…
There is some very hopeful data out there this morning on cancer survival. Bristol-Myers Squibb Co. (NYSE: BMY) and Medarex,…
Bristol-Myers Squibb (NYSE: BMY) has sent a letter to Imclone Systems (NASDAQ: IMCL) in response to yesterday’s rejection of its…
ImClone Systems Inc. (NASDAQ: IMCL) is a biotech buyout bonanza stock that traders and investors have been watching closely. The…
According to Reuters, large Yahoo! (YHOO) holder Capital Research want to know whether vote counts from the company’s annula meeting…
Carl Icahn and friends at ImClone Systems Incorporated (NASDAQ: IMCL) have now formally responded to Bristol-Myers Squibb Company (NYSE: BMY)…
According to Reuters, GM (GM) is expected to post a huge loss. Reuters reports that oil company profits rose, but…
Our top personal finance-related articles today. Your wallet will thank you later.